ATE418737T1 - Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom - Google Patents

Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom

Info

Publication number
ATE418737T1
ATE418737T1 AT04763899T AT04763899T ATE418737T1 AT E418737 T1 ATE418737 T1 AT E418737T1 AT 04763899 T AT04763899 T AT 04763899T AT 04763899 T AT04763899 T AT 04763899T AT E418737 T1 ATE418737 T1 AT E418737T1
Authority
AT
Austria
Prior art keywords
spee
marker
colorectal carcinoma
diagnosis
spermidine synthase
Prior art date
Application number
AT04763899T
Other languages
English (en)
Inventor
Michael Tacke
Peter Berndt
Marie-Luise Hagmann
Johann Karl
Hanno Langen
Stefan Palme
Markus Roessler
Wolfgang Rollinger
Werner Zolg
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE418737T1 publication Critical patent/ATE418737T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/9116—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • G01N2333/91165—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5) general (2.5.1)
    • G01N2333/91171—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5) general (2.5.1) with definite EC number (2.5.1.-)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04763899T 2003-08-08 2004-08-06 Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom ATE418737T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03017585 2003-08-08

Publications (1)

Publication Number Publication Date
ATE418737T1 true ATE418737T1 (de) 2009-01-15

Family

ID=34130059

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04763899T ATE418737T1 (de) 2003-08-08 2004-08-06 Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom

Country Status (6)

Country Link
US (1) US20060188950A1 (de)
EP (1) EP1654542B1 (de)
AT (1) ATE418737T1 (de)
DE (1) DE602004018650D1 (de)
ES (1) ES2318318T3 (de)
WO (1) WO2005015231A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1676134B1 (de) * 2003-10-15 2008-04-23 Roche Diagnostics GmbH Verwendung des proteins spee als marker für brustkrebs
CN110257313B (zh) * 2019-05-16 2020-12-08 华中农业大学 一株产亚精胺的解淀粉芽孢杆菌工程菌

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2440703A1 (en) * 2001-01-24 2002-08-01 Protein Design Labs, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
EP1676134B1 (de) * 2003-10-15 2008-04-23 Roche Diagnostics GmbH Verwendung des proteins spee als marker für brustkrebs

Also Published As

Publication number Publication date
EP1654542A1 (de) 2006-05-10
US20060188950A1 (en) 2006-08-24
ES2318318T3 (es) 2009-05-01
WO2005015231A1 (en) 2005-02-17
DE602004018650D1 (de) 2009-02-05
EP1654542B1 (de) 2008-12-24

Similar Documents

Publication Publication Date Title
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
ATE554389T1 (de) Apex als marker für lungenkrebs
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
MX340856B (es) Sistema y metodos que determinan concentracion de analito utilizando amperometria resuelta en tiempo.
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
NO339224B1 (no) Bedrede immunprøvemetoder
CY1112553T1 (el) Ανοσοπροσδιορισμοι υψηλης ευαισθησιας και κιτια για τον προσδιορισμο πεπτιδιων και πρωτεϊνων βιολογικου ενδιαφεροντος
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
ATE430936T1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE359516T1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE418737T1 (de) Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom
ATE531822T1 (de) Diagnose von prostatakrebs
ATE410691T1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
FR2894675B1 (fr) Distinction des meningites bacteriennes et virales

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1654542

Country of ref document: EP